Baird Financial Group’s Barinthus Biotherapeutics BRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$179K Buy
2025
Q1
$89.9K Hold
2024
Q4
$112K Hold
2024
Q3
$110K Sell
2024
Q2
$375K Buy
2024
Q1
$399K Sell
2023
Q4
$724K Hold
2023
Q3
$607K Hold
2023
Q2
$404K Buy
2023
Q1
$402K Buy
2022
Q4
$217K Buy